Connect with us

Technology

New survey finds UAE emerging as a global tech hub for Asian talent

Published

2 years ago

on

Eight out of 10 Asian tech professionals recognise UAE’s growing reputation as a tech hub; 45% of tech workers would relocate to the UAE, outperforming Germany and Hong Kong as a popular relocation destination for tech talent;93% of respondents think it is important to have a government that is supportive of the tech industry

DUBAI, UAE, Sept. 18, 2024 /PRNewswire/ — A recent survey conducted by Capital.com, a global trading platform and the Middle East’s fastest-growing technology company*, has revealed that the United Arab Emirates (UAE) is rapidly gaining recognition as a competitive tech hub. The survey polled 1,000 respondents across Singapore, Hong Kong, Vietnam and India, and found that 81% of Asian tech professionals view the UAE as a growing tech hub. A further 76% of respondents say the UAE provides a conducive environment for the tech industry.

The UAE’s growing reputation as a burgeoning tech hub is fuelling interest among tech workers across the region, with nearly half (45%) of respondents expressing a willingness to relocate to the UAE for work, out-ranking countries like Germany (38%) and Hong Kong (20%) as popular relocation destinations.

This places the UAE in close competition with other prominent destinations such as Singapore (46%), the UK (57%), and the US (52%) as preferred locations for relocation among tech professionals.

Commenting on the findings, Tarik Chebib, CEO, Capital.com, Middle East, said:

“With 8 in 10 respondents from our recent survey recognising the UAE as a competitive tech hub, it’s clear that the region is gaining momentum as a favourable destination for tech talent. Asia’s tech professionals have traditionally gravitated to cities in the UK, the US and Singapore to further their careers, so it’s encouraging to see the UAE stand shoulder-to-shoulder with this cohort and get the recognition it deserves as an attractive location to live and work.”

Government support is the key factor contributing to UAE’s growing reputation as a tech hub and relocation destination of choice. Of those surveyed, 93% think it is important to have a government that is supportive of the tech industry, highlighting the UAE’s concentrated push to develop the country as a hotspot for international tech talent. 

The majority of those surveyed (74%) cite the UAE’s banking, visa, special healthcare/health insurance packages, and real estate services for qualified tech professionals, as factors. More broadly, respondents also say that a high quality of life (60%), attractive remuneration (54%) and the UAE’s strategic location (52%) also feed into their decision to relocate.

“As a leading partner of the UAE’s NextGenFDI initiative, we have seen first-hand the government’s commitment to support and grow the tech sector. The UAE’s business-friendly environment, forward-thinking policies, investment in innovation, and position as a gateway to the Middle East, Africa and Asia, makes it an ideal location for companies and talent alike. Capital.com is proud to contribute to the sector’s growth and innovation in the UAE.” said Chebib.

While all respondents indicated a ‘willingness’ to relocate for work, 47% indicated that they are ‘actively’ looking to relocate, highlighting the huge potential for the UAE to attract and retain tech talent.

“As a company operating in the UAE that is licensed by the Securities and Commodities Authority (SCA), we need to draw on an exceptional pool of talent to meet our exacting business and regulatory needs. This means searching for the best talent, from anywhere in the world. Given the UAE’s pro-talent stance and growing appeal as a tech destination for professionals, we have had no problem recruiting talent from as far afield as the UK, Europe and Australia. Employees are eager to relocate to a country that not only supports their personal needs but also provides fertile ground for further development within the tech sector,” added Chebib.

Capital.com opened its UAE subsidiary and regional headquarters in March 2024. Based in Dubai, Capital Com MENA Securities Trading LLC (Capital Com MENA), is licensed and regulated by the UAE Securities and Commodities Authority (SCA). Capital.com is also a leading member of the UAE’s #NextGenFDI initiative, a government-led initiative enabling cutting-edge companies from around the world to establish and expand their operations in the UAE. In 2022, Capital.com was a sponsor of the UAE’s NextGen Talent initiative, which was aimed at developing the capabilities of local youth and preparing future leaders in the technology sector.

Survey methodology:

The survey was carried out between 11 and 28 July 2024 and fielded responses from 1,000 respondents who currently work in a variety of tech-related roles in Singapore, Hong Kong, Vietnam or India, and had declared they were open to relocating to another country for work. The sample split was 250 respondents from Hong Kong, 250 respondents from Singapore, 250 respondents from Vietnam, and 250 respondents from India.  

Notes to Editors

About Capital.com:

Capital.com enables clients to trade derivatives on more than 3,000 of the world’s most popular indices, commodities, cryptocurrencies, shares, and currency pairs. In addition to its web and mobile-based platforms, Capital.com also provides clients with access to free education and trading tools to help them hone their trading knowledge.

As a global fintech company with offices in London, Dubai, Limassol, Melbourne, Warsaw, and Vilnius, Capital.com is guided by a sustainability-led startup framework, prioritising smart partnerships with the public and private sector to help drive progress and sustainable growth.

Capital Com (UK) Limited is authorised and regulated by the Financial Conduct Authority (FCA) under registration number 793714. Capital Com SV Investments Limited is Authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC), under licence number 319/17. Capital Com Australia Pty Ltd is authorised and regulated by the Australian Securities and Investments Commission (ASIC) under AFSL Number 513393. Capital Com Online Investments Ltd is a Company registered in the Commonwealth of The Bahamas and authorised to carry out Securities Business by the Securities Commission of The Bahamas with licence number SIA-F245. Capital Com Mena Securities Trading LLC is authorised and regulated by the Securities and Commodities Authority (SCA), under license number 20200000176.

To find out more, please visit:  www.capital.com

This press release is for media use only. It’s not intended for individual investors, and doesn’t include personal advice or recommendations.

DISCLAIMER

Spread bets and/or CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 83.51% of retail investor accounts lose money when trading spread bets and/or CFDs with this provider. You should consider whether you understand how spread bets and/or CFDs work and whether you can afford to take the high risk of losing your money. Professional clients can lose more than they deposit. All trading involves risk.

Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd. Spread bets are available only to UK clients.

The value of shares and ETFs bought through a share dealing account can fall as well as rise, which could mean getting back less than you originally put in. Past performance is no guarantee of future results.

Capital Com (UK) Limited (“CCUK”) is registered in England and Wales with company registration number 10506220. CCUK is authorised and regulated by the Financial Conduct Authority (“FCA”), under registration number 793714. Capital Com SV Investments Limited (“CCSV”) is registered in Cyprus with company registration number 354252. CCSV is regulated by Cyprus Securities and Exchange Commission (CySEC) under licence number 319/17. Capital Com Australia Pty Ltd is authorised and regulated by the Australian Securities and Investments Commission (ASIC) under AFSL Number 513393. Capital Com Online Investments Ltd is a limited liability company (company number 209236B) registered in the Commonwealth of The Bahamas and authorised to carry on Securities Business by the Securities by the Securities Commission of The Bahamas (“SCB”) with licence number SIA-F245. Capital Com Mena Securities Trading LLC is authorised and regulated by the Securities and Commodities Authority (SCA), under license number 20200000176.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.

Photo –  https://mma.prnewswire.com/media/2507974/Tarik_Chebib_CEO.jpg
Logo – https://mma.prnewswire.com/media/2507973/Capital_com.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/new-survey-finds-uae-emerging-as-a-global-tech-hub-for-asian-talent-302251110.html

Related Topics:
Continue Reading

Technology

HiTHIUM Partners with the University of Cambridge to Advance International Industry-Academia Collaboration in Long-Duration Energy Storage

Published

30 seconds ago

on

November 14, 2026

By

XIAMEN, China, Nov. 14, 2026 /PRNewswire/ — On November 12, the Global Energy Storage Colloquium was held in Xiamen. During the colloquium, HiTHIUM and the University of Cambridge signed a memorandum of understanding (MoU), establishing a strategic partnership. The two parties will collaborate on frontier scientific research, key technology innovation and industrial applications in battery energy storage, bringing academic research into closer alignment with industry needs and exploring new models for international industry-academia collaboration. The partnership aims to contribute to the advancement of global energy storage technology and the industry.

The UK has a strong track record in the development of modern battery technologies and fundamental research. The University of Cambridge is one of the world’s leading universities, with internationally recognized expertise in engineering, materials science and fundamental research. As a leading global energy storage technology company, HiTHIUM has long focused on energy storage technology development and commercialization. It continues to advance integrated research and innovation across the value chain, from high-capacity energy storage cells to long-duration energy storage systems and grid integration technologies.

The collaboration is intended to bring internationally leading academic research into closer engagement with innovation across China’s energy storage industry. The University of Cambridge’s strengths in fundamental science, materials research and engineering will offer new perspectives and approaches to key scientific questions and emerging technologies in energy storage. HiTHIUM will bring its experience in long-duration energy storage (LDES), product development and large-scale deployment, connecting research with real industry needs and application scenarios, and supporting the engineering validation and commercialization of research outcomes. By drawing on the strengths of both research and industry, the partnership will strengthen the links between frontier innovation and practical applications.

Under the cooperation plan, the two parties will establish joint management and research collaboration mechanisms, bringing together academic resources and corporate R&D capabilities. They will work together to plan research projects, facilitate scientific exchange and support the translation of research outcomes, strengthening connections between fundamental research, technology development and industrial applications so that innovation in energy storage can better serve industry needs.

The partnership also marks an important step in HiTHIUM’s efforts to expand its international innovation network. Building on this collaboration with the University of Cambridge, HiTHIUM will further strengthen academic exchanges and research partnerships with leading universities and research institutions around the world. By bringing together international research resources and talent, the company aims to encourage collaboration across disciplines and technology fields, explore the development of technologies such as LDES from a global perspective, and bring technical challenges and application needs from the front lines of industry into research and innovation. This will help research and industrial practice reinforce one another.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hithium-partners-with-the-university-of-cambridge-to-advance-international-industry-academia-collaboration-in-long-duration-energy-storage-302939492.html

SOURCE HiTHIUM

Continue Reading

Technology

The NYSE Welcomes vVARDIS as a Publicly Listed Company

Published

60 minutes ago

on

November 14, 2026

By

NEW YORK, Nov. 14, 2026 /PRNewswire/ — vVARDIS (NYSE: VVVV) co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world’s #1 non-communicable disease: cavities.

vVARDIS Solves a Problem that Millions FaceTooth decay affects billions of people worldwide, and dental anxiety keeps millions from getting the care they need.vVARDIS is a Swiss dental technology company focused on changing the way early tooth decay is treated.vVARDIS has introduced a new approach that aims to treat decay earlier and more comfortably for patients.Its flagship product, Curodont® Repair Fluoride Plus, uses proprietary peptide technology to help repair early-stage tooth decay by supporting the natural remineralization of enamel — simply put No drill, No needle, or No filling.Tooth Decay is One of the Most Common Health Issues in the World2.5 billion people globally live with untreated tooth decay.Nearly 90% of U.S. adults have experienced tooth decay.Nearly 73% of U.S. adults report dental fear.21% avoid the dentist because of anxiety.The Story that Helped Shape vVARDISFor decades, treating early tooth decay often meant waiting until it worsened or getting a filling. The founders spent 25 years developing Curodont® Repair Fluoride Plus, a treatment that helps repair early tooth decay before it becomes a cavity.Curodont® gives dentists a way to treat early decay while making the experience easier and less intimidating for patients.The technology has already treated more than 2.5 million teethAvailable in more than 20% of U.S. dental practices

Click Here to Learn More about vVARDIS: https://www.youtube.com/watch?v=T1p9hUR5Glk

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/the-nyse-welcomes-vvardis-as-a-publicly-listed-company-302939487.html

SOURCE New York Stock Exchange

Continue Reading

Technology

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

Published

4 hours ago

on

November 14, 2026

By

SHANGHAI, Nov. 14, 2026 /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50 on the first trading day, up 68% from the IPO price, giving the company a market capitalization of approximately $1.69 billion. This is Qiming Venture Partners’ 11th IPO in 2026.

Qiming Venture Partners invested in Windward Bio’s inaugural Series A financing in 2025 and continued to support the company in its Series B financing in 2026. Qiming also participated in this IPO financing round.

Windward Bio was founded in 2024 with a mission to transform the treatment paradigm for patients living with chronic inflammatory diseases through the development of differentiated biologic therapies targeting clinically validated disease pathways. Led by a team with extensive expertise across discovery, development, and commercialization, Windward Bio is advancing a pipeline of ultra-long-acting antibody medicines to improve clinical outcomes, reduce treatment burden and expand treatment options for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease (COPD) and atopic dermatitis.

Windward Bio’s lead program, WIN378, is a potentially novel anti-TSLP monoclonal antibody engineered for improved potency and extended half-life. WIN378 is currently being evaluated in POLARIS-1, a Phase 2/3 study in severe uncontrolled asthma, and SIRIUS, a Phase 2 study in COPD. The company’s pipeline also includes WIN027, a clinical-stage, long-acting bispecific antibody targeting TSLP and IL-13 with potential applications across multiple inflammatory and immunological diseases. Windward Bio holds exclusive global rights (excluding Greater China and certain Asian countries) to WIN378 through a licensing agreement with Kelun-Biotech and Harbour BioMed, and has separately licensed WIN027 from Qyuns Therapeutics.

“Qiming Venture Partners invests in differentiated, globally competitive biotech innovation designed to address significant unmet needs for patients, and Windward Bio exemplifies this approach. We believe novel, long-acting biologics will reshape the treatment of severe chronic respiratory and skin diseases, and that WIN378 and WIN027 have the potential to expand and meaningfully improve the treatment options available to patients. In the hands of Luca and his team, with their expertise and proven track record, Windward is well-positioned to deliver on this potential, and we look forward to supporting the company through its next phase of growth,” said Alexander Sinclair Wilson, Principal at Qiming Venture Partners.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 630 fast-growing and innovative companies. Over 290 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 110 portfolio companies that have achieved unicorn or super unicorn status.

Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, HyperStrong, Insta360, Unisound, Biren Technology, Z.AI, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, Insilico Medicine, AusperBio, Yuanxin Technology, Medilink Therapeutics, LaNova Medicines, StepFun, among many others.

 

View original content:https://www.prnewswire.com/news-releases/innovative-immunology-biotech-windward-bio-lists-on-nasdaq-302939481.html

SOURCE Qiming Venture Partners

Continue Reading

Trending